Enhancement of bone regeneration by coadministration of angiogenic and osteogenic factors using messenger RNA.

"Declarations Ethics approval and consent to participateAnimal experiments were approved by Institutional Animal Care and Use Committee at Tokyo Medical and Dental University (A2021477). Consent for publicationNot applicable. Competing interestsThe authors declare they have no conflicts of interest. Competing interests The authors declare they have no conflicts of interest."

"Funding This research was financially supported in part by the Japan Agency for Medical Research and Development (AMED), Japan, under Grant Number 22fk0310515s0501 (K.I.) and 22ak0101173s0202 (K.I.), TMDU WISE II Program from Japan Science and Technology Agency(JST), under Grant Number G4304 (M.Z.), and Japan–China Sasakawa Medical Fellowship, under Grant Number 2110〔II〕031 (M.Z.). This research was also supported in part by Axcelead, Inc."